Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A major investment bank just signaled a powerful vote of confidence in Lilly's GLP-1 strategy. This article breaks do...
South Korea's possible investment in NuScale Power's SMR program could shift the nuclear landscape and offer new oppo...
Nuscale Power stock rocketing headlines point to optimism around small modular reactors, policy momentum, and utility...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
A high-stakes order from China could reshape Boeing’s revenue trajectory. Here’s how to think about the stock in 2026...
Whispers of a Caesars takeover are fueling a strong price on Kalshi. This article explains what a 68% probability mea...
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Backlogs can unlock revenue visibility, but they can also mask quality issues. This article explains how to assess or...
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Oil markets react quickly to SPR chatter. This article explains what potential strategic petroleum releases could mea...